Literature DB >> 21349436

Big science for a big problem: ADNI enters its second phase.

Adrian Burton.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21349436     DOI: 10.1016/S1474-4422(11)70031-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  5 in total

1.  NIA commentary: translational issues in Alzheimer's disease drug development.

Authors:  Neil S Buckholtz; Laurie M Ryan; Suzana Petanceska; Lorenzo M Refolo
Journal:  Neuropsychopharmacology       Date:  2012-01       Impact factor: 7.853

2.  The Global Alzheimer's Association Interactive Network.

Authors:  Arthur W Toga; Scott C Neu; Priya Bhatt; Karen L Crawford; Naveen Ashish
Journal:  Alzheimers Dement       Date:  2015-08-28       Impact factor: 21.566

3.  A way forward for research on biomarkers for psychiatric disorders.

Authors:  Patricia Boksa
Journal:  J Psychiatry Neurosci       Date:  2013-03       Impact factor: 6.186

Review 4.  Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.

Authors:  J Scott Roberts; Wendy R Uhlmann
Journal:  Prog Neurobiol       Date:  2013-04-09       Impact factor: 11.685

5.  The pipeline system for Octave and Matlab (PSOM): a lightweight scripting framework and execution engine for scientific workflows.

Authors:  Pierre Bellec; Sébastien Lavoie-Courchesne; Phil Dickinson; Jason P Lerch; Alex P Zijdenbos; Alan C Evans
Journal:  Front Neuroinform       Date:  2012-04-03       Impact factor: 4.081

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.